Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient level meta-analysis of 37,298 women with early breast cancer in 26 randomised trials

Early Breast Cancer Trialists' Collaborative Group (EBCTCG); David Cameron

doi:10.1016/S0140-6736(18)33137-4

Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient level meta-analysis of 37,298 women with early breast cancer in 26 randomised trials

Early Breast Cancer Trialists' Collaborative Group (EBCTCG), David Cameron

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	The Lancet
DOIs	https://doi.org/10.1016/S0140-6736(18)33137-4
Publication status	Published - 7 Feb 2019

Access to Document

10.1016/S0140-6736(18)33137-4Licence: Creative Commons: Attribution (CC-BY)

DC OA
Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
Final published version, 925 KBLicence: Creative Commons: Attribution (CC-BY)

Cite this

@article{07f44ae570574ec48816736b16851082,

title = "Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient level meta-analysis of 37,298 women with early breast cancer in 26 randomised trials",

author = "{Early Breast Cancer Trialists' Collaborative Group (EBCTCG)} and David Cameron",

year = "2019",

month = feb,

day = "7",

doi = "10.1016/S0140-6736(18)33137-4",

language = "English",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier",

}

Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient level meta-analysis of 37,298 women with early breast cancer in 26 randomised trials. / Early Breast Cancer Trialists' Collaborative Group (EBCTCG) ; Cameron, David.
In: The Lancet, 07.02.2019.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient level meta-analysis of 37,298 women with early breast cancer in 26 randomised trials

AU - Early Breast Cancer Trialists' Collaborative Group (EBCTCG)

AU - Cameron, David

PY - 2019/2/7

Y1 - 2019/2/7

U2 - 10.1016/S0140-6736(18)33137-4

DO - 10.1016/S0140-6736(18)33137-4

M3 - Article

SN - 0140-6736

JO - The Lancet

JF - The Lancet

ER -